Home / Semaglutide / Side effects
Semaglutide side effects
FDA-approved Wegovy US label (revised 06/2026): 2.4 mg vs placebo in three trials of up to 68 weeks.
Short answer: Nausea is the most common side effect, reported by 44% of people on Wegovy 2.4 mg vs 16% on placebo, followed by diarrhea, vomiting and constipation. They are most frequent while the dose is being raised. 6.8% stopped because of side effects, vs 3.2% on placebo.
How common each side effect is
| Side effect | Placebo | Wegovy 2.4 mg |
|---|---|---|
| Nausea | 16% | 44% |
| Diarrhea | 16% | 30% |
| Vomiting | 6% | 24% |
| Constipation | 11% | 24% |
| Abdominal pain | 10% | 20% |
| Headache | 10% | 14% |
| Fatigue | 5% | 11% |
| Indigestion (dyspepsia) | 3% | 9% |
| Dizziness | 4% | 8% |
| Bloating | 5% | 7% |
| Burping | <1% | 7% |
| Acid reflux (GERD) | 3% | 5% |
| Hair loss | 1% | 3% |
Percent of people reporting each effect. Wegovy label, section 6.1, Table 3.
Other numbers worth knowing
| Any stomach or gut side effect | 73% vs 47% on placebo; severe in 4.1% vs 0.9% |
| Stopped because of side effects | 6.8% vs 3.2% on placebo (nausea was the top reason) |
| Wegovy 7.2 mg (higher dose) | Nausea 39%, vomiting 22%, and skin sensitivity or burning (dysesthesia) 22% vs 6% on 2.4 mg |
| Hair loss | 4% of women vs 0.9% of men; 8.4% of women at 7.2 mg |
| Heart rate | Average increase of 1-4 beats per minute |
| Gallstones | 1.6% vs 0.7% on placebo |
| Low blood pressure / fainting | 1.3% vs 0.4%; 0.8% vs 0.2% |
When side effects happen
The label says stomach and gut reactions "were most frequently reported during dosage escalation."
Boxed warning
Risk of thyroid C-cell tumors seen in rodents; it is not known whether semaglutide causes them in humans. Do not use with a personal or family history of medullary thyroid cancer or MEN 2.
Serious risks on the label
- Pancreatitis
- Gallbladder disease
- Low blood sugar (with diabetes medicines)
- Kidney injury from dehydration
- Severe stomach and gut reactions
- Serious allergic reactions
- Diabetic eye disease getting worse (type 2 diabetes)
- Faster heart rate
- Breathing in stomach contents during anesthesia or deep sedation
Not medical advice. Contact your prescriber about side effects that are severe or do not go away, and get urgent care for severe stomach pain, signs of an allergic reaction or trouble breathing.
More on Semaglutide: dosage and status ·units calculator
Side effects of: Tirzepatide · Retatrutide · BPC-157
Questions
- What is the most common side effect of semaglutide?
- Nausea: 44% of people on Wegovy 2.4 mg vs 16% on placebo. Diarrhea (30%), vomiting (24%) and constipation (24%) follow.
- Does the 7.2 mg Wegovy dose cause more side effects?
- Somewhat more vomiting (22% vs 16% on 2.4 mg in the same trials), and a much higher rate of skin sensitivity or burning sensations (dysesthesia): 22% vs 6%. The label says it rose with dose.
- Are Ozempic side effects the same as Wegovy?
- Both are semaglutide and share the same warnings. The rates on this page are from the Wegovy weight-loss trials at 2.4 mg; Ozempic's label reports its own trials in type 2 diabetes at lower doses.
- Is suicidal thinking a Wegovy warning?
- Not anymore. The Wegovy label removed the suicidal behavior and ideation warning in January 2026.
Sources
- Wegovy (semaglutide) US prescribing information, Novo Nordisk
- Ozempic (semaglutide) US prescribing information, Novo Nordisk
- Wilding et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). NEJM 2021
- FDA approves higher-dose semaglutide under the national priority voucher program (Mar 2026)
Last checked 2026-11-16. How we pick and check sources: methodology.